|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2010-11-16
|
|
pubmed:abstractText |
Ocular surface disease (OSD) is a common side effect of ophthalmic medications containing the preservative benzalkonium chloride (BAK). Little is known whether and how glaucoma treatment patterns and annual costs vary based on the presence of BAK. The objective of this analysis was to estimate first-year treatment costs among new initiators of topical prostaglandin analogs in a managed care population.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1473-4877
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2769-77
|
|
pubmed:meshHeading |
pubmed-meshheading:21043550-Administration, Topical,
pubmed-meshheading:21043550-Adolescent,
pubmed-meshheading:21043550-Adult,
pubmed-meshheading:21043550-Aged,
pubmed-meshheading:21043550-Aged, 80 and over,
pubmed-meshheading:21043550-Algorithms,
pubmed-meshheading:21043550-Child,
pubmed-meshheading:21043550-Child, Preschool,
pubmed-meshheading:21043550-Cohort Studies,
pubmed-meshheading:21043550-Eye Diseases,
pubmed-meshheading:21043550-Female,
pubmed-meshheading:21043550-Health Care Costs,
pubmed-meshheading:21043550-Health Resources,
pubmed-meshheading:21043550-Humans,
pubmed-meshheading:21043550-Infant,
pubmed-meshheading:21043550-Infant, Newborn,
pubmed-meshheading:21043550-Male,
pubmed-meshheading:21043550-Middle Aged,
pubmed-meshheading:21043550-Prostaglandins, Synthetic,
pubmed-meshheading:21043550-Retrospective Studies,
pubmed-meshheading:21043550-Review Literature as Topic,
pubmed-meshheading:21043550-Time Factors,
pubmed-meshheading:21043550-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
First-year treatment costs among new initiators of topical prostaglandin analog identified from November 2007 through April 2008.
|
|
pubmed:affiliation |
Managing Scientist, Exponent Inc., Alexandria, VA, USA. jschmier@exponent.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
